Develops self-balancing AI-powered exoskeletons and humanoid robots for rehabilitation, personal mobility and industry.
| Date | Round | Amount |
|---|---|---|
| Jun 2025 | Series D Plus Wandercraft closed a $75M Series D to expand the Atalante X and Eve exoskeletons and the new Calvin humanoid robot line, with Renault Group and Bpifrance among the investors. | $75M |
| Jan 2022 | Series C Wandercraft raised a USD45M Series C led by Quadrant Management for its exoskeletons. | $45M |